[DOI] [PubMed] [Google Scholar] 692
In tendon and ligament injury models, BPC-157 speeds up growth factor expressionspecifically VEGF, EGF, and tenascinwithin fibroblasts and tenocytes, helping with extracellular matrix remodelling and cellular migration into damaged tissue
Serious side effects of the medication include the following: Allergic or hypersensitivity reaction Severe gastrointestinal issues Changes in mood and behavior Pancreatitis Liver problems Low blood sugar levels (hypoglycemia) Cardiac arrhythmias Suicidal ideation Major depressive disorder No adverse event of hypoglycemia or thyroid cancer was reported in Phase II trials, and 7% of retatrutide participants had skin sensitivity, compared to 1% on placebo, but these cases were not serious
A medical consultation is required before starting any peptide-based weight management program
The body cannot make B12 on its own
Transcript abundance was quantified with Kallisto, and differentially expressed genes (DEGs) were identified using DESeq2
